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Results: The DIR performs well visually and the sum of squares for the 
difference between the deformed CTs and the real CTs ranged 
between 4x109 and 5x109. For comparison, the difference between 
four volumes in which only noise generates differences between the 
images, gave a comparable SQD of around 3.7 x 109. For all the image 
pairs, the SQD of the deformed CTs is approximately half of that of 
the non-registered images (ranging from 0.45 to 0.59).  
Conclusions: A limitation of an US based deformation field is that the 
area of the CT on which one can perform the deformation field is 
limited to the area of which US data is available. However, this 
phantom experiment does show that the application of such an US 
based CT DIR in principle could work. Whether the US based CT DIR is 
also valid for patient cases, has to be studied further with patient 
examples.  
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Purpose/Objective: To assess the impact of respiratory-gated PET-CT 
(4D-PET-CT) on SUV quantification in lung tumors. 
Materials and Methods: 19 patients with lung tumors who had 18FDG-
PET-CT were studied with a 4D-PET-CT additional acquisition after a 
whole body scan. Patients were selected among the group that 
showed respiratory-induced tumor motion greater than 5 mm. 4D-PET-
CT was performed by means of a Philips Gemini BigBore TOF scanner 
capable of time-of-flight reconstruction, using the Varian RPM gating 
system. Administration and acquisition parameters were 3.0 MBq/kg 
18FDG, 2 min/bed, retrospective-mode for both PET and CT 
modalities. Patients were instructed to breath as regularly as possible. 
Data were reconstructed in 1 (no sorting), 4, 5, 6, 7, 8, 9 and 10 
breathing phases. SUVmax values within the lesion were studied as a 
function of the number of phases in phase(0%) (max expiration). 
Lesion volumes were also obtained by three different methods: a) 
fixed SUV=2.2 threshold, b) 40% of SUVmax isocontour and c) gradient-
based method. The volumes were also studied as a function of the 
number of phases in phase(0%). 
Results: The observed maximum range of motion was 5.5mm(L-R), 
16.5mm(A-P) and 22.2mm(S-I). SUVmax was on average 67.4% higher 
in the gated acquisition (10 phases) compared to the non-gated case 
(range 13.1%-328.3%). When comparing reconstructions in 4 and 10 
phases, the average increase in SUVmax reduced to 13.3% (range 2.3%-
31.2%). Corresponding figures for 6 to 10-phase comparison were 6.8% 
and range 0.0%-23.1%. In general, volumes estimated by the fixed-
threshold method increased with increasing phase number, volumes 
obtained with the percentage method decreased and volumes 
obtained with the gradient-based method did not show a significant 
trend. On average, volumes calculated in the 10-phase ph(0) image by 
method a) were 8.9% higher than volumes obtained by method b), 
while in the static acquisition (no gating) method a) gave volumes 20% 
smaller than method b), on average. 
Conclusions: 4D-PET-CT offers a clear advantage in 18F-FDG SUV 
estimation for tumors that move with respiration. The balance 
between acquisition/reconstruction time, signal-to-noise ratio and 
SUV estimation accuracy seems to be achievable splitting the 
respiratory cycle into 4 to 6 phases, depending on lesion location. The 
same observation holds for lesion volumes, however further research 
is needed to determine the optimal segmentation method. Gradient-
based methods are less sensitive to the number of phases for volume 
estimation, however further study is necessary to fine-tune and 
validate their results. 
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Purpose/Objective: Quantitative objective analyses are widely used 
in radiology. These are relevant in oncology as well, since the use of 
pelvic CBCT for adaptive RT requires a certain level of image quality. 
The purpose of this study is to objectively evaluate the clinical image 
quality of two systems; a state-of-the-art CBCT system and a new 
CBCT system with improved reconstruction and hardware.  
Materials and Methods: The patients included in this retrospective 
study had a planning CT and CBCT's from Clinac iX as well as 
Truebeam (Varian Medical Systems). Based on European Guidelines 
provided by CEC seven quality criteria in relation to the bladder on 
CBCT were defined along with an ordinal rating scale reflecting the 
fulfillment of a particular criterion. The corresponding author and a 
number of physicians rated in a randomized order the CT's and the 
pelvic CBCT's. The resulting data were evaluated by a statistical 
analysis called Visual Grading Characteristics (VGC) in the free 
software DBM MRMC 2.32 Build 3. The difference in image quality 
between the two modalities was evaluated by the area under the 
curve (AUC) and ANOVA. An AUC of 0.5 indicated equally image 
quality whereas higher values indicated superior image quality. If 0.5 
was not included in the 95% confidence interval the difference in 
image quality of the systems was significant. A VGC curve comprising 
the total image quality criteria was found for each observer. 
Furthermore, the impact of the individual criteria was demonstrated 
by a VGC curve and the respective AUC. The Image Criteria Score (ICS) 
was calculated for the total and individual criteria and ideally ICS 
would equal 1.0. As a reference the VGC analysis of the CT was 
performed.  
Results: An excerpt of the results of the corresponding author is 
included for five criteria (Figure 1). The VGC curves clearly illustrate 
better performance of Truebeam than Clinac iX for criterion I-IV, 
whereas the performance is more equivocal regarding criterion V. The 
AUC was 0.68 for the total quality criteria and the 95% confidence 
interval was [0.55, 0.80]. For criterion I the AUC was 0.72, criterion II 
yielded an AUC of 0.71, criterion III an AUC of 0.73, criterion IV an 
AUC of 0.70 and for criterion V AUC was 0.47. The total ICS for 
Truebeam and Clinac iX was 0.49 and 0.27, respectively. For the 
individual criteria the ICS was higher for Truebeam than Clinac iX. The 
percentage difference ranged between 11.1 and 33.3 percentage 
points. 
